Amidst the pressing public health challenges of high mortality rates and compromised quality of life, the significance of effective asthma management comes into sharp focus. This year’s World Asthma Day theme, “Asthma Education Empowers,” underscores the vital role of knowledge in enhancing asthma management and patient outcomes. With India ranking #1 in prevalence and disability-adjusted life years (DALYs) due to asthma, in addition to accounting for 42% of all asthma-related deaths worldwide, this year’s theme amplifies the urgency for national-level mobilization to address this critical issue. 1, 2, 3
Effective asthma management is multifaceted and awareness efforts must be supported by an ecosystem that encompasses various aspects of care. From disease and therapy awareness to diagnostics, screening, counselling, and treatment adherence, every step in the asthma journey matters. The collaboration between public awareness campaigns like Cipla’s Berok Zindagi and Tuffies, along with patient support efforts such as the company’s Breathefree initiative, creates a network of support for patients. Breathefree encompasses both physical and digital components, including an AI-enabled device training platform. This network not only assists patients but also provides relief to their families.
Commenting on the importance of education empowered action, Dr. Ritam Chakraborty, Consultant Pulmonologist & Critical Care Specialist, Kolkata said, “Characterized by narrowed airways, increased sensitivity to triggers (like dust mites, smoke, cold air etc.) and changes in the air passages, Asthma is a long-term/chronic disease. Although incurable, it can be controlled through timely diagnosis and medical intervention. However, misconceptions, especially about inhalation therapy, often lead to patients failing to follow their doctor’s advice. In fact, only about 23% of patients in India call their condition by its actual name with the rest referring to it as something like a cold and cough. By increasing awareness, not only among patients but also within the broader community, we can ensure timely diagnosis and appropriate management, ultimately leading to better health outcomes for asthma patients. 4
Emphasizing the importance of education to ensure early intervention and treatment adherence, Dr. Debopam Chatterjee, Interventional Pulmonologist & Sleep Medicine Specialist, Kolkata said, “Asthma management aims to achieve optimal symptom control, to prevent attacks and any impact on quality of life. This is usually achieved through a combination of maintenance and reliever therapies. Inhalation therapy serves as a cornerstone, greatly enhancing quality of life. Infact, for certain patient populations like children or seniors who struggle with quick inhalation, nebulized treatments offer a practical solution, especially during acute exacerbations. However, it’s concerning that less than 9% of diagnosed patients use inhalation therapy with misconceptions about inhalers playing a leading role in treatment non-adherence. These challenges are further magnified by other factors like limited healthcare access, inadequate device training and guidance. Therefore, to address these issues, a fundamental shift in how we approach asthma care in India is needed.” 5, 6, 7
By prioritizing awareness and building a supportive ecosystem, Cipla remains dedicated to ensuring that patients receive the necessary support throughout their asthma journey. With Berok Zindagi, Cipla has challenged asthma misconceptions and its treatment related stigmas through a multitude of creative mediums. While the Tuffies campaign has evolved into a movement of inspiration for kids with respiratory conditions such as asthma and their caregiver through engaging comic books as well as on-ground school programs like the Tuffies Ki School Yatra.
Parallelly, Cipla’s Breathefree initiative has been instrumental in providing comprehensive support resources for asthma patients in the areas of screening, counselling, and treatment adherence. From on-ground screening camps, to a now AI enabled Breathefree Digital Educator platform and device training ‘how-to’ videos; Breathefree has evolved into a one-stop support solution for those living with asthma.
For more information visit: www.breathefree.com


Disclaimer:

This information is only for general awareness and is not to promote, use, or endorse any product or encourage use of medicines in any way nor implied to be a substitute for professional medical advice nor for diagnosis or treatment/ cure of any medical condition. The views expressed are independent opinion based on studies from authentic sources. Your discretion may be exercised before using the information for consulting doctor. Please consult your doctor/ Registered Medical Practitioner before starting any treatment/medicine/ inhaler. This is being used only as a reference to create awareness and is NOT intended towards advertisement.

Ref:

  1. Wang, Zhufeng et al. “Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.” Respiratory research vol. 24,1 169. 23 Jun. 2023, doi:10.1186/s12931-023-02475-6
  2. Mortimer, Kevin1,2; Salvi, Sundeep Santosh3,4; Reddel, Helen K.5,6, *. Closing gaps in asthma care in India – World Asthma Day 2022. Indian Journal of Medical Research 156(1): p 6-9, July 2022. | DOI: 10.4103/ijmr.ijmr_893_22
  3. Salvi, Sundeep1,2,; Madas, Sapna1; Ghorpade, Deesha1; Gadhave, Swapnil1; Barne, Monica1. Is underuse of Inhaled Corticosteroids for Asthma in India contributing to 42% of global asthma deaths?. Lung India 39(4):p 331-336, Jul–Aug 2022. | DOI: 10.4103/lungindia.lungindia_600_21
  4. Singh S, Salvi S, Mangal DK, et al. Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study. ERJ Open Res 2022; 8: 00528-2021 [DOI: 10.1183/ 23120541.00528-2021].
  5. Scichilone, Nicola. “Asthma control: the right inhaler for the right patient.” Advances in therapy vol. 32,4 (2015): 285-92. doi:10.1007/s12325-015-0201-9
  6. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  7. Virchow, J C et al. “Importance of inhaler devices in the management of airway disease.” Respiratory medicine vol. 102,1 (2008): 10-9. doi:10.1016/j.rmed.2007.07.031

Leave a Comment

Your email address will not be published. Required fields are marked *